Laryngeal dystonia

Otolaryngologic Clinics of North America

Volumn 39, Issue 1, 2006, Pages 87-100

  Grillone, Gregory A ^a   Chan, Teresa ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; BACLOFEN; BENZATROPINE; BENZODIAZEPINE; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BOTULINUM TOXIN C 2; BOTULINUM TOXIN C1; BOTULINUM TOXIN D; BOTULINUM TOXIN E; BOTULINUM TOXIN F; BOTULINUM TOXIN G; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; CLONAZEPAM; CLOZAPINE; DIAZEPAM; LIDOCAINE; LORAZEPAM; TRIHEXYPHENIDYL; UNCLASSIFIED DRUG;

BLURRED VISION; CEREBRAL PALSY; CLINICAL EXAMINATION; COGNITIVE DEFECT; CONCENTRATION LOSS; DISEASE CLASSIFICATION; DRUG BINDING AND TRANSPORT; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; DRUG STRUCTURE; DYSPHAGIA; DYSTONIA; EATON LAMBERT SYNDROME; FLU LIKE SYNDROME; GASTROESOPHAGEAL REFLUX; HOARSENESS; HUMAN; INJECTION PAIN; LARYNGEAL NERVE; LARYNX DISORDER; LARYNX SURGERY; MYASTHENIA GRAVIS; NONHUMAN; REVIEW; TREATMENT OUTCOME; WEAKNESS; XEROSTOMIA;

BOTULINUM TOXINS; DYSTONIA; HUMANS; INJECTIONS, INTRAMUSCULAR; LARYNGEAL DISEASES; LARYNGEAL MUSCLES; VOICE DISORDERS;

EID: 32044473524     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2005.11.001     Document Type: Review

References (58)

1. A. Blitzer, and M. Brin Spasmodic dysphonia: evaluation and management M.P. Fried The larynx: a multidisciplinary approach 2nd edition. 1996 Mosby-Year Book Inc Salem (MA) 187 198
2. L. Traube Spastische form der Nervösen Heiserkeit Gesammelte Beitr Pathol Physiol 2 1871 677
3. A. Blitzer, R.E. Lovelace, and M.F. Brin Electromyographic findings in focal laryngeal dystonia (spasmodic dysphonia) Ann Otol Rhinol Larngol 94 1985 591 594
4. M.F. Brin, S. Fahn, and A. Blitzer Movement disorders of the larynx A. Blitzer M.F. Brin C.T. Sasaki Neurological disorders of the larynx 1992 Thieme Medical Publishers New York 240 248
5. A. Blitzer, M.F. Brin, and C. Stewart Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients Laryngoscope 108 10 1998 1435 1441
6. J.M. Schweinfurth, M. Billante, and M. Courey Risk factors and demographics in patients with spasmodic dysphonia Laryngoscope 112 2002 220 223
7. R.H. Miller, and G.E. Woodson Treatment options in spasmodic dysphonia Otolaryngol Clin North Am 24 5 1991 1227 1237
8. L. Ozelius, P.L. Kramer, and C.B. Moskowitz Human gene for torsion dystonia located on chromosome 9q32-34 Ann Neurol 27 1990 114 120
9. P.L. Kramer, D. de Leon, and L. Ozelius Dystonia gene in Ashkenazi Jewish population is located on chromosome 9q32-34 Ann Neurol 27 1990 114 120
10. M.P. Cannito, and P. Johnson Spastic dysphonia: a continuum disorder J Commun Disord 14 1981 215
11. M. Feldman, J.V. Nixon, and T. Finitzo-Hieber Abnormal parasympathetic vagal functions in patients with spastic dysphonia Ann Intern Med 100 1984 491
12. S.D. Schafer, R.M. Roark, and B.C. Watson Vocal tract electromyographic abnormalities in spasmodic dysphonia: preliminary report Trans Am Laryngol Assoc 108 1987 187
13. L.G. Cohen, C.L. Ludlow, and M. Warden Blink reflex excitability recover curves in patients with spasmodic dysphonia Neurology 39 1979 572
14. M.P. Cannito, and G.V. Kondraske Rapid manual abilities in spasmodic dysphonia and normal female subjects J Speech Hear Res 33 1990 123
15. T. Langeveld, E. Houtman, and J. Briaire Evaluation of voice quality in adductor spasmodic dysphonia before and after botulinum toxin treatment Ann Otol Rhinol Laryngol 110 2001 627 634
16. G. Woodson Use of flexible fiberoptic laryngoscopy to assess patients with spasmodic dysphonia J Voice 5 1991 85
17. P. Zwirner, T. Murry, and M. Swenson Effects of botulinum toxin therapy in patients with adductor spasmodic dysphonia: acoustic, aerodynamic and videoendoscopic findings Laryngoscope 102 1992 400 406
18. G.A. Grillone, A. Blitzer, and M.F. Brin Treatment of adductor laryngeal breathing dystonia with botulinum toxin Laryngoscope 104 1 1994 30 32
19. T. Shipp, K. Izdebski, and H.K. Schutte Subglottal air pressure in spastic dysphonia speech Folia Phoniatr (Basel) 40 3 1988 105 110
20. P. Zwirner Acoustic changes in spasmodic dysphonia after botulinum toxin injection J Voice 5 1991 78
21. G.E. Woodson, P. Zwirner, and T. Murry Functional assessment of patients with spasmodic dysphonia J Voice 6 1992 338 343
22. J.A. Koufman New classification of laryngeal dystonias The Visible Voice 1 1992 1 5
23. C.L. Ludlow, and N.P. Connor Dynamic aspects of phonatory control in spasmodic dysphonia J Speech Hear Res 30 2 1987 197 206
24. M. Morrison, and L. Rammage Musculoskeletal approach to the classification of dysphonias The management of voice disorders 1994 Singular Publishing Group San Diego (CA) 53 63
25. H.H. Dedo Recurrent laryngeal nerve section for spastic dysphonia Ann Otol Rhinol Laryngol 85 1976 451
26. H. Dedo, and M.S. Behlau Recurrent laryngeal nerve section for spastic dysphonia: 5- to 14-year preliminary results in the first 300 patients Ann Otol Rhinol Laryngol 100 1991 274
27. A.E. Aronson, and L.W. Desanto Adductor spastic dysphonia: three years after laryngeal nerve section Laryngoscope 93 1983 1
28. H.F. Biller, M. Som, and W. Lawson Laryngeal nerve crush for spastic dysphonia Ann Otol Rhinol Laryngol 92 1983 469
29. H. Tucker Laryngeal framework surgery in the management of spasmodic dysphonia: preliminary report Ann Otol Rhinol Laryngol 98 1989 52 54
30. N. Isshiki, D.H. Tsuji, and Y. Yamamoto Midline lateralization thyroplasty for adductor spasmodic dysphonia Ann Otol Rhin Laryngol 109 2000 187 193
31. M. Friedman, D.M. Toriumi, and V. Grybauskas Treatment of spastic dysphonia without nerve section Ann Otol Rhinol Laryngol 96 5 1987 590 596
32. G.S. Berke, K.E. Blackwell, and B.R. Gerratt Selective laryngeal adductor denervation-reinnervation: a new surgical treatment for adductor spasmodic dysphonia Ann Otol Rhinol Laryngol 108 3 1999 227 231
33. M. Remacle, I. Plouin-Gaudon, and G. Lawson Bipolar radiofrequency- induced thermotherapy (rfitt) for the treatment of spasmodic dysphonia. A report of three cases Eur Arch Otorhinolaryngol 2005
34. A.B. Scott Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery Opthalmology 87 1980 1044 1049
35. A. Blitzer, M.F. Brin, and S. Fahn Botulinum toxin (BOTOX) for the treatment of "spastic dysphonia" as part of a trial of toxin injections for the treatment of other cranial dystonias Laryngoscope 96 11 1986 1300 1301
36. A. Blitzer, and L. Sulica Botulinum toxin: basic science and clinical uses in otolaryngology Laryngoscope 111 2 2001 218 226
37. M.F. Brin Botulinum toxin therapy: basic science and overview of other therapeutic applications A. Blitzer W.J. Binder J.B. Boyd Management of facial lines and wrinkes 2000 Lippincott Williams & Wilkins Philadelphia 279 302
38. G.E. Borodic, L.B. Pearce, and K. Smith Botulinum A toxin for spasmodic torticollis: multiple vs. single injection points per muscle Head Neck 14 1992 33
39. C.M. Shaari, and I. Sanders Quantifying how location and dose of botulinum toxin injections affect muscle paralysis Muscle Nerve 16 1993 964 969
40. G.M. Fillipi, P. Errico, and R. Santarelli Botulinum A toxin effect on rat jaw muscles spindles Acta Otolaryngol (Stockh) 113 1993 400
41. A.B. Scott, and D. Suzuki Systemic toxicity of botulinum toxin by intramuscular injection in the money Mov Disor 3 1988 333 335
42. F.S. Pidcock The emerging role of therapeutic botulinum toxin in the treatment of cerebral palsy J Pediatr 145 2 Suppl 2004 S33 S35
43. L.A. Koman, A. Brashear, and S. Rosenfeld Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial Pediatrics 108 5 2001 1062 1071
44. T. Mezaki, R. Kaji, and N. Kohara Development of general weakness in a patient with amyotrophic lateral sclerosis after focal botulinum toxin injection Neurology 46 1996 845 846
45. P.J. Tuite, and A.E. Lang Severe and prolonged dysphagia complicating botulinum toxin A injections for dysponia in Machado-Joseph disease Neurology 46 1996 846
46. M.F. Brin Botulinum toxin: chemistry, pharmacology, toxicity, and immunology Muscle Nerve Suppl 6 1997 S146 S168
47. P. Green, S. Fahn, and B. Diamond Development of resistance to botulinum toxin type A in patients with torticollis Mov Disor 9 1994 213 217
48. A.D. Sheppert, G.A. Spirou, and A.S. Berrebi Three-dimensional reconstruction of immunolabeled neuromuscular junctions in the human thyroarytenoid muscle Laryngoscope 113 11 2003 1973 1976
49. C.N. Ford, D.M. Bless, and J.D. Lowery Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia Otolaryngl Head Neck Surg 103 1990 752
50. L. Sulica, A. Blitzer, and M.F. Brin Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section Ann Otol Rhinol Laryngol 112 6 2003 499 505
51. A. Blizter, M.F. Brin, and S. Fahn Botulinum toxin therapy for recurrent laryngeal nerve section failure for adductor laryngeal dystonia Trans Am Laryngol Assoc 110 1989 206
52. C.L. Ludlow, R.F. Naunton, and M. Fujita Spasmodic dysphonia: botulinum toxin injection after recurrent laryngeal nerve surgery Otol Head Neck Surg 102 1990 122
53. C.L. Ludlow, R.F. Naunton, and S. Terada Successful treatment of selected cases of abductor spasmodic dysphonia using botulinum toxin injection Otolaryngol Head Neck Surg 104 1991 840
54. M.P. Cannito Perceptual analysis of spasmodic dysphonia before and after treatment Arch Otolaryngol Head Neck Surg 130 12 2004 1393 1399
55. Available at: http://www.cochrane.org/colloquia/abstracts/capetown/ capetownPB30.html. Accessed July 1, 2005.
56. G.E. Borodic, and R. Ferrante Effects of repeated botulinum toxin injections on orbicularis oculi muscle J Clin Neuro-Ophthalmol 12 1992 121 127
57. T. Ansved, T. Odergren, and K. Brog Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia Neurology 48 1997 1440 1442
58. D.B. Sanders, E.W. Massey, and E.G. Buckley Botulinum toxin for blepharospasm: single fiber EMG studies Neurology 36 1986 544 547